{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Pseudouridimycin: Light in the Darkness of Antimicrobial Resistance

Purpose of Activity

To provide information on antimicrobial resistance (AMR) and the role of pseudouridimycin (PUM).

Learning Objectives/Outcomes

After completing this continuing education activity you will be able to:

  1. Outline the epidemiology and development of AMR.
  2. Select examples of drug-resistant pathogens and methods to combat AMR.
Price: $12.95

Credits:

  • ANCC 1.0 CH / 0.5 APH
  • DC - BON 1.0 CH
  • FL - BON 1.0 CH
  • GA - BON 1.0 CH

Lippincott Professional Development is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, and Georgia Board of Nursing, #50-1223.

Awarded Advanced Pharmacology Hours







Test Code: CNS0518
Published: May/Jun 2018
Expires: 6/4/2020
Passing Score: 11/15 (73%)
Authors: Patricia Anne O'Malley, PhD, RN, CNS